Genetic testing for gynaecological cancer
نویسندگان
چکیده
منابع مشابه
Gynaecological Cancer
Endometrial cancer generally has a good prognosis because most cases are diagnosed in stage I. It is possible to identify subgroups of patients with early-stage endometrial cancer with a poor prognosis. Despite a traditional generous use of adjuvant radiotherapy, these patients have five-year overall survival of approximately 80%. In this group there is a need for an effective systemic adjuvant...
متن کاملGenetic Testing for Breast and Ovarian Cancer
Genetic testing for breast and ovarian cancer has been publicly available since the mid-1990 discovery of two breast/ovarian cancer susceptibility genes named BRCA1 and BRCA2. Although many professionals say that genetic testing may be the best available preventative medicine breakthrough, controversy abounds over whether the medical benefits of BRCA1/2 mutation testing outweigh the psychologic...
متن کاملUptake of genetic testing for cancer predisposition.
Although there has been much debate about the uptake and effects of predictive testing for common cancers, such as breast and colon cancer, little has been published on the more classical tumour predisposing conditions, such as von Hippel-Lindau disease and familial adenomatous polyposis. Since 1990 the genetics departments in Manchester and Cambridge have had a genetic register for cancer pred...
متن کاملA New Enzyme Test for Gynaecological Cancer
The ease of collection of preparations of exfoliated cells from the female genital tract has facilitated the recent widespread interest in cytodiagnostic tests for cancer, particularly of the cervix uteri. If cervical cells are readily available for cytological preparations they are also accessible to biochemical study. Such a biochemical study of exfoliated malignant and premalignant cells hol...
متن کاملGenetic testing in cancer therapeutics.
A major challenge to physicians administering drugs with a low therapeutic index, such as chemotherapeutic agents, is the variability in drug disposition and clearance. This variability accounts for the wide interpatient response to conventional doses of antineoplastic agents. Currently, most dosing regimens are based on body weight or surface area, with the decision for dose modifications typi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Obstetrics, Gynaecology & Reproductive Medicine
سال: 2017
ISSN: 1751-7214
DOI: 10.1016/j.ogrm.2016.11.001